Patent of the Week
Our flagship weekly feature. Each edition spotlights a single patent with standout growth potential, examining its market opportunity, innovation strength, and what it signals for IP investors.
Patent of the Week: Polyglutamated Antifolates and Their Therapeutic Delivery
LEAF Holdings Group LLC advances cancer and autoimmune treatment with innovative drug formulation technology
LEAF Holdings Group LLC's patent on polyglutamated antifolates encapsulated in liposomes presents a novel approach to treating hyperproliferative and immune disorders. With a significant citation count and a strong technical foundation, this patent highlights strategic value in the HEALTHTECH sector.
Read the full featurePast Editions
Patent of the Week: HMGB1 Antagonist Treatment Advances Sepsis Care
US11524048B2 represents a significant advancement in sepsis therapy using proteolysis targeting chimera technology for selective degradation of the HMGB1 protein. The Feinstein Institutes for Medical Research holds this high-impact patent, signaling promising commercial and licensing potential in the burgeoning biopharma landscape.
Jul 14, 2026Patent of the Week: Attention-based sequence transduction neural networks reshape AI
US10452978B2, assigned to Google LLC, covers pioneering attention-based neural network architectures that have transformed sequence transduction in AI. This foundational technology drives breakthroughs in NLP and speech recognition, establishing a high-value asset with broad commercial and licensing potential.
Jun 28, 2026Patent of the Week: Method and apparatus for pulse gas delivery with concentration measurement
MKS Instruments quietly owns the plumbing of modern chipmaking. This week we break down a precision gas-delivery patent that sits at the heart of advanced semiconductor fabrication, and why IP investors should be paying attention as AI chip demand accelerates.